Erstlinien-Erhaltungstherapie bei Patienten mit Tumor ohne EGFR-aktivierende Mutationen ohne Nutzen – Indikationseinschränkung.
We are the Swiss agency for the authorisation and supervision of therapeutic products (medicinal products and medical devices). We fulfil our legal mandate and work with partner authorities on a national and international basis.
We endeavour to ensure that authorised therapeutic products are of high quality, effective and safe.
By doing so, we make a considerable contribution towards protecting the health of humans and animals, and we also participate in safeguarding Switzerland as a location for industry and research.
The Swissmedic Portal will be offline
|Wednesday||28.09.2016||22:00 – 23:30 (CEST)|
due to planned maintenance work.
Swissmedic is mandated to carry out a considerable proportion of the penal prosecutions for violations of legislation on therapeutic products. The Agency may carry out penal investigations and may impose sanctions. More information...